HPV and cervical cancer testing and prevention: Knowledge, beliefs, and attitudes among hispanic women

Qualitative Health Research

Volumn 18, Issue 5, 2008, Pages 584-596

  Vanslyke, Jan Gaylord ^a   Baum, Julie ^b   Plaza, Veronica ^c   Otero, Maria ^b   Wheeler, Cosette ^c   Helitzer, Deborah L ^c  

^a Coletta Reid and Associates ^*  (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

Cancer; Community and public health; Decision making; Focus groups; Health behavior; Health care; Health education; Latino Hispanic people; Prevention; Psychosocial aspects; Screening; Women's health

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE;

ADULT; ARTICLE; ATTITUDE TO ILLNESS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; COMMUNITY CARE; CONDOM; CONDYLOMA ACUMINATUM; DISEASE ASSOCIATION; FEMALE; HEALTH BEHAVIOR; HEALTH BELIEF; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HIGH RISK PATIENT; HISPANIC; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICAL INFORMATION; PAPANICOLAOU TEST; PATIENT EDUCATION; PRIMARY PREVENTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PUBLIC HEALTH; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; VACCINATION; VIRUS DETECTION; VIRUS TRANSMISSION; WOMEN'S HEALTH;

ADOLESCENT; ADULT; CONDOMS; DNA, VIRAL; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES, VIRAL; SOCIOECONOMIC FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 42249110539     PISSN: 10497323     EISSN: 15527557     Source Type: Journal    
DOI: 10.1177/1049732308315734     Document Type: Article

References (62)

1. Ajzen, I. (2005). Attitudes, personality, and behavior (2nd ed.). Milton-Keynes, England: Open University Press/McGraw-Hill.
2. American Cancer Society. (2006). Cancer facts and figures for Hispanics/ Latinos 2006-2008. Atlanta, GA: Author.
3. American College of Obstetricians and Gynecologists. (2005, April). Human Papillomavirus. ACOG Practice Bulletin, 61, 905-918.
4. Anhang, R., Wright, R.C., Jr., Smock, L., & Goldie, S.J. (2004). Women's desired information about human papillomavirus. Cancer, 100, 315-320.
5. Arbyn, M., Sasieni, P., Meijer, C.J.L.M., Clavel, C., Koliopoulos, G., & Dillner, J. (2006). Clinical applications of HPV testing: A summary of meta-analyses. Vaccine, 24S3, 78-89.
6. Bandura, A. (1977). Social learning theory. Englewood Cliffs, NJ: Prentice Hall.
7. Barnabas, R.V., Laukkanen, P., Koskela, P., Kontula, O., Lehtinen, M.,. & Garnett, G.P. (2006). Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: Mathematical modeling analysis. PLoS Medicine, 3(5), e138.
8. Bowen, D.J., Allen, J.D., Vu, T., Johnson, R.E., Fryer-Edwards, K., & Hart, A. (2006). Theoretical foundations for interventions designed to promote informed decision making for cancer screening. Annals of Behavioral Medicine, 32(3), 202-210.
9. Breitkopf, C.R., Pearson, H.C., & Breitkopf, D.M. (2005). Poor knowledge regarding the Pap test among low-income women undergoing routine screening. Perspectives on Sexual and Reproductive Health, 37(2), 78-84.
10. Burchell, A.N., Winer, R.L., de Sanjosé, S., & Franco, E.L. (2006). Epidemiology and transmission dynamics of genital HPV infection. Vaccine, 24S3, 52-61.
11. Centers for Disease Control and Prevention. (2005). Final report on HPV clinician survey: Knowledge, attitudes, practices about genital HPV infection and related conditions. Atlanta, GA: Author.
12. Colgrove, J. (2006). The ethics and politics of compulsory HPV vaccination. New England Journal of Medicine, 355(23), 2389-2391.
13. Cuzick, J., Mayrand, M.H., Ronco, G., Snijders, P., & Wardle, J. (2006). New dimensions in cervical cancer screening. Vaccine, 24S3, 90-97.
14. Davis, K., Dickman, E.D., Ferris, D., & Dias, J.K. (2004). Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. Obstetrical & Gynecological Survey, 59(12), 820-822.
15. Documet, P.I., & Sharma, R.K. (2004). Latinos' health care access: Financial and cultural barriers. Journal of Immigrant Health, 6(1), 5-13.
16. Elbasha, E.H., Dasbach, E.J., & Insinga, R.P. (2007). Model for assessing human papillomavirus vaccination strategies. Emerging Infectious Diseases, 13(1), 28-41.
17. Fey, M.C., & Beal, M.W. (2004). Role of human papilloma virus testing in cervical cancer prevention. Journal of Midwifery & Women's Health, 49(1), 4-13.
18. Franco, E.L., Durarte-Franco, E., & Ferenczy, A. (2001). Cervical cancer: Epidemiology, prevention and the role of human papillomavirus infection. Canadian Medical Association Journal, 164(7), 1017-1025.
19. Friedman, A.L., & Shepeard, H. (2006). Exploring the knowledge, attitudes, beliefs and communication preferences of the general public regarding HPV: Findings from CDC focus group research and implications for practice. Health Education and Behavior. Prepublished September 22. DOI:10.1177/1090-198106292022.
20. Garner, E.I. (2003). Cervical cancer: Disparities in screening, treatment and survival. Cancer Epidemiology Biomarkers & Prevention, 12(3), 242-247.
21. Gilbert, L.K., Alexander, L., Grosshans, J.F., & Jolley, L. (2003). Answering frequently asked questions about HPV. Sexually Transmitted Diseases, 30, 193-194.
22. Granada-Cameron, C. (1999). The experience of having cancer in Latin America. Cancer Nursing, 22(1), 51-57.
23. Harper, D.M. (2004). Why am I scared of HPV? CA: A Cancer Journal for Clinicians, 54, 245-247.
24. Helmerhorst, T.J., & Meijer, C.J. (2002). Cervical cancer should be considered as a rare complication of oncogenic HPV infection rather than a STD. International Journal of Gynecological Cancer, 12, 235-236.
25. Ho, G.Y., Bierman, R., Beardsley, L., Chang, C.J., & Burk, R.D. (1998). Natural history of cervicovaginal papillomavirus infection in young women. New England Journal of Medicine, 338, 423-428.
26. Holmes, K.K., Levine, R., & Weaver, M. (2004). Effectiveness of condoms in preventing sexually transmitted infections. Bulletin of the World Health Organization, 82, 454-461.
27. Jain, N., Irwin, K.L., Montano, D., Kasprzyk, D., Carlin, L., Freeman, C., et al. (2006). Family physicians' knowledge of genital human papillomavirus (HPV) infection and HPV-related conditions, United States, 2004. Family Medicine, 38(7), 483-489.
28. Janz, N.K., & Becker, M. (1984). The health belief model: A decade later. Health Education & Behavior, 11(1), 1-47.
29. Jastreboff, A.M., & Cymet, T. (2002). Role of the human papillomavirus in the development of cervical intraepithelial neoplasia and malignancy. Postgraduate Medical Journal, 78, 225-228.
30. Kahn, J.A., Zimet, G.D., Bernstein, D.I., Riedesel, J.M., Dongmei, L., Huang, B., et al., (2005). Pediatricians' intention to administer human papillomavirus vaccine: The role of practice characteristics, knowledge, and attitudes. Journal of Adolescent Health, 37, 502-510.
31. Kaiser Family Foundation National Survey of Public Knowledge of HPV, the Human Papillomavirus. (2000). Retrieved July, 2004, from http://www.kff.org/womenshealth/upload/133851.pdf
32. Katz, M.K., Wewers, M.E., Single, N., & Paskett, E.D. (2007). Key informants' perspectives prior to beginning a cervical cancer study in Ohio Appalachia. Qualitative Health Research, 17, 131.
33. Koutsky, L.A., & Harper, D.M. (2006). Current findings from prophylactic HPV vaccine trials. Vaccine, 24S3, 114-121.
34. Lindau, S.T., Tomori, C., Langseth, L., Bennett, C.L., & Garcia, P. (2002). The association of health literacy with cervical cancer prevention knowledge and health behaviors in a multiethnic cohort of women. American Journal of Obstetrics and Gynecology, 186, 938-943.
35. Mahoney, M.C., Saslow, D., & Cohen, C.J. (2003). American Cancer Society [ACS] guideline for the early detection of cervical cancer. American Family Physician, 67(8), 1677-1678, 1680.
36. Maissi, E., Marteau, T.M., Hankins, M., Legood, R., & Gray, A. (2005). The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6 month follow-up. British Journal of Cancer, 92, 990-994.
37. Manhart, L.E., & Koutsky, L.A. (2002). Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sexually Transmitted Diseases, 29(11), 725-735.
38. Mays, R.M., Zimet, G.D., Winston, Y., Kee, R., Dickes, J., & Su, L. (2000). Human papillomavirus, genital warts, Pap smears, and cervical cancer: Knowledge and beliefs of adolescent and adult women. Health Care for Women International, 21(5), 361-374.
39. Muñoz, N., Castellsague, X., de Gonzalez, A.B., & Gissmann, L. (2006). HPV in the etiology of human cancer. Vaccine, 24(3), S1-S10.
40. National Center for Education Statistics. (2006). National assessment of adult literacy: A first look at the literacy of America's adults in the 21st Century. Washington, DC: U.S. Department of Education, Institute of Education Sciences.
41. National Institute for Allergy and Infectious Diseases. (2002). Strategic plan for addressing health disparities, fiscal years 2002-2006. Retrieved April, 2005, from http://www.cancer.org/downloads/ stt/Estimated_New_Cancer_Cases_and_Deaths_by_Sex_for_ All_Sites,_US,_2005.pdf
42. Revzina, N.V., & DiClemente, R.J. (2005). Prevalence and incidence of human papillomavirus infection in women in the USA: A systematic review. International Journal of STD/AIDS, 16(8), 528-537.
43. Riedesel, J.M., Rosenthal, S.L., Zimet, G.D., Bernstein, D.I., Huang, B., Lan, D., et al. (2005). Attitudes about human papillomavirus vaccine among family physicians. Journal of Pediatric and Adolescent Gynecology, 18, 391-398.
44. Saaty, T.L. (1990). The analytic hierarchy process. Pittsburgh, PA: RWS. (Original work published 1980).
45. Saslow, D., Runowicz, C.D., Solomon, D., Moscicki, A.B., Smith, R.A., Eyre, H.J., et al. (2003). American Cancer Society guidelines for the early detection of cervical neoplasia and cancer. Journal of Lower Genital Tract Disease, 7(2), 67-86.
46. Sharpe, P.A., Brandt, H.M., & McCree, D.H. (2006). Knowledge and beliefs about abnormal Pap test results and HPV among women with high-risk HPV results from in-depth interviews. Women and Health, 42(2), 107-133.
47. Sherris, J., Friedman, A., Wittet, S., Davies, P., Steben, M., & Saraiya, M. (2006). Education, training and communication for HPV vaccines. Vaccine, 24S3, 210-218.
48. Smith, L.A. (2003). Partner influence on noncondom use: Gender and ethnic differences. Journal of Sex Research, 40(4), 346-350.
49. Stone, K.M., Karem, K.I., Sternberg, M.R., McQuillan, G.M., Poon, A.D., Unger, E.R., et al., (2002). Seroprevalence of HPV 16 in the United States. Journal of Infectious Diseases, 186(10), 1396-1402.
50. Summers, A. (1998). Mental health consequences of cervical screening. Psychology, Health and Medicine, 3, 113-126.
51. Sussman, A., Helitzer, D., Urquieta, B., Sanders, M.L., Salvador, M., & Ndiaye, K. (2007). HPV and cervical cancer prevention counseling: A fit or misfit for primary care visits with younger adolescents ? Annals of Family Medicine, 5, 298-304.
52. Van Til, L., MacQuarrier, C., & Herbert, R. (2003). Understanding the barriers to cervical cancer screening among older women. Qualitative Health Research, 13, 1116.
53. Waller, J., McCaffery, K.J., Forrest, S., & Wardle, J. (2004). Human papillomavirus and cervical cancer: Issues for biobehavioral and psychosocial research. Annals of Behavioral Medicine, 27(1), 68-79.
54. Ward, E., Jemal, A., Cokkinides, V., Singh, G.K., Cardinez, C., Ghafoor, A., et al. (2004). Cancer disparities by race/ethnicity and socioeconomic status. CA: A Cancer Journal for Clinicians, 54, 78-93.
55. Wilkinson, R., & Marmot, M.G. (1999). Social determinants of health. Oxford, UK: Oxford University Press.
56. Winer, R.L., Hughes, J.P., Feng, Q., O'Reilly, S., Kiviat, N.B., Holmes, K.K., et al. (2006). Condom use and the risk of genital human papillomavirus infection in young women. New England Journal of Medicine, 354, 2645-2654.
57. Winer, R.L., Lee, S.K., Hughes, J.P., Adam, D.E., Kiviat, N.B., & Loutsky, L.A. (2003). Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students. American Journal of Epidemiology, 157, 218-226.
58. Wright, T.C., Jr., Cox, J.T., Massad, L.S., Twiggs, L.B., & Wilkinson, E.J. (2002). 2001 consensus guidelines for the management of women with cervical abnormalities. Journal of the American Medical Association, 287, 2120-2129.
59. Wright, T.C., Jr., Schiffman, M., Solomon, D., Cox, J.T., Garcia, F., Goldie, S., et al. (2004). Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstetrics and Gynecology, 103, 304-309.
60. Zambrana, R.E., Cornelius, L.J., Sims Boykin, S., & Salas Lopez, D. (2004). Latinas and HIV/AIDS risk factors: Implications for harm reduction strategies. American Journal of Public Health, 94, 1152-1158.
61. Zimet, G.D., Mays, R.M., Sturm, L.A., Ravert, A.A., Perkins, S.M., & Juliar, B.E. (2005). Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Archives of Pediatric & Adolescent Medicine, 159, 132-137.
62. Zimet, G.D., Mays, R.M., Winston, Y., Kee, R., Dickes, J., & Su, L. (2000). Acceptability of human papillomavirus immunization. Journal of Women's Health and Gender-Based Medicine, 9, 47-50.